Compile Data Set for Download or QSAR
Report error Found 62 Enz. Inhib. hit(s) with all data for entry = 50007407
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062648(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 50nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062648(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 50nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062645(3-[(2-Chloro-4-trifluoromethyl-pyrimidine-5-carbon...)
Affinity DataIC50: 120nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062658(3-[(2-Chloro-4-trifluoromethyl-pyrimidine-5-carbon...)
Affinity DataIC50: 150nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062645(3-[(2-Chloro-4-trifluoromethyl-pyrimidine-5-carbon...)
Affinity DataIC50: 170nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062658(3-[(2-Chloro-4-trifluoromethyl-pyrimidine-5-carbon...)
Affinity DataIC50: 280nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062669(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 380nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062669(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 490nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062661(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 500nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062663(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 500nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062661(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 500nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062653(3-[(2-Chloro-4-trifluoromethyl-pyrimidine-5-carbon...)
Affinity DataIC50: 620nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062653(3-[(2-Chloro-4-trifluoromethyl-pyrimidine-5-carbon...)
Affinity DataIC50: 660nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062663(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 800nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062650(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 900nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062650(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 900nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062651(3-[(2-Chloro-4-trifluoromethyl-pyrimidine-5-carbon...)
Affinity DataIC50: 1.20E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062656(3-[(2-Chloro-4-trifluoromethyl-pyrimidine-5-carbon...)
Affinity DataIC50: 1.20E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062672(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 1.20E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062672(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 1.60E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062656(3-[(2-Chloro-4-trifluoromethyl-pyrimidine-5-carbon...)
Affinity DataIC50: 1.80E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062651(3-[(2-Chloro-4-trifluoromethyl-pyrimidine-5-carbon...)
Affinity DataIC50: 1.80E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062652(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 2.30E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062673(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 2.30E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062649(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 2.70E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062649(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 2.70E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062673(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 2.80E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062671(3-[(2-Chloro-4-trifluoromethyl-pyrimidine-5-carbon...)
Affinity DataIC50: 3.00E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062652(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 3.00E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062674(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 3.00E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062659(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 3.80E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062668(2-Piperidin-1-yl-4-trifluoromethyl-pyrimidine-5-ca...)
Affinity DataIC50: 4.00E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062659(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 4.00E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062671(3-[(2-Chloro-4-trifluoromethyl-pyrimidine-5-carbon...)
Affinity DataIC50: 4.60E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062668(2-Piperidin-1-yl-4-trifluoromethyl-pyrimidine-5-ca...)
Affinity DataIC50: 5.00E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062674(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 5.00E+3nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062657(4-Trifluoromethyl-pyrimidine-5-carboxylic acid (3,...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062654(2-Phenylamino-4-trifluoromethyl-pyrimidine-5-carbo...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062655(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062647(2-Butylamino-4-trifluoromethyl-pyrimidine-5-carbox...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062644(2-Hydroxy-4-trifluoromethyl-pyrimidine-5-carboxyli...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062646(2-Benzylamino-4-trifluoromethyl-pyrimidine-5-carbo...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062646(2-Benzylamino-4-trifluoromethyl-pyrimidine-5-carbo...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062670(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062660(2-Methoxy-4-trifluoromethyl-pyrimidine-5-carboxyli...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062667(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062664(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclic AMP-dependent transcription factor ATF-1(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062657(4-Trifluoromethyl-pyrimidine-5-carboxylic acid (3,...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with activating transcription factor 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062670(2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Signal Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50062665(2-Dimethylamino-4-trifluoromethyl-pyrimidine-5-car...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against human Jurkat T-Cells stably transfected with an Nuclear factor kappa B transcription factorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 62 total ) | Next | Last >>
Jump to: